BMHS: PT Bundamedik Tbk - Summary | Jitta

PT Bundamedik Tbk

IDN:BMHS

Price
Rp185.00
Loss Chance
50.8%
3.86JITTA SCORE
> 1,000%Over Jitta Line
Jitta Ranking
347 / 855
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (49)
Recent Business Performance (56)
Financial Strength (63)
Return to Shareholders (10)
Competitive Advantage (37)
Jitta Signs
Cash Conversion CycleLess than 60 days
Revenue and EarningRevenue decline from 2022-2025
Operating MarginInconsistent
Debt LevelVery High Long Term Debt
Recent Business PerformanceEarning decline 41.02% in the last quarter (yoy)
CapExVery High
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
3.86
> 1,000%
4.29
428.89%
Health Care Facilities
3.95
> 1,000%
5.66
40.28%
7.07
37.63%
COMPANY DESCRIPTION
PT Bundamedik Tbk provides health care services in Indonesia. It also engages private hospital and healthcare support service activities; provision of ambulance services; private health education; consultant for reproductive technology services management; management consultant of physiotherapy service; and hotel, medical tourism, and dental clinic services management consulting businesses. It also provides fertility clinic, and oncology; emergency services; laboratory, radiology, and IVF services; and genomics and clinical pathology laboratory, and corporate health services. In addition, the company operates a BMHS nurse center, bunda neuro centre, bunda heart centre, bunda urology centre, digital substraction angiography, RSM oncology, and advanced robotic minimal invasive surgery. PT Bundamedik Tbk was founded in 1973 and is based in Jakarta Pusat, Indonesia. PT Bundamedik Tbk is a subsidiary of PT Bunda Investama Indonesia.